Integrated Diagnostics Holdings plc
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron… Read more
Integrated Diagnostics Holdings plc (IDGXF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.051x
Based on the latest financial reports, Integrated Diagnostics Holdings plc (IDGXF) has a cash flow conversion efficiency ratio of 0.051x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($197.02 Million) by net assets ($3.83 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Integrated Diagnostics Holdings plc - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Integrated Diagnostics Holdings plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Integrated Diagnostics Holdings plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Integrated Diagnostics Holdings plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BATM Advanced Communications Ltd.
PINK:BVCLF
|
N/A |
|
Lucero Energy Corp
V:LOU
|
0.042x |
|
Fission 3.0 Corp
V:FUU
|
-0.021x |
|
Korea Information Certificate Authority Inc
KQ:053300
|
0.019x |
|
Brockhaus Technologies AG
LSE:0AAW
|
-0.045x |
|
Sasken Technologies Limited
NSE:SASKEN
|
-0.025x |
|
Questerre Energy Corporation
PINK:QTEYF
|
0.010x |
|
Veranda Learning Solutions Limited
NSE:VERANDA
|
0.042x |
Annual Cash Flow Conversion Efficiency for Integrated Diagnostics Holdings plc (2012–2024)
The table below shows the annual cash flow conversion efficiency of Integrated Diagnostics Holdings plc from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $3.50 Billion | $1.57 Billion | 0.448x | +155.65% |
| 2023-12-31 | $3.10 Billion | $543.66 Million | 0.175x | +105.54% |
| 2022-12-31 | $2.45 Billion | $208.73 Million | 0.085x | -89.50% |
| 2021-12-31 | $2.79 Billion | $2.27 Billion | 0.812x | +123.33% |
| 2020-12-31 | $2.43 Billion | $882.51 Million | 0.364x | +23.09% |
| 2019-12-31 | $2.36 Billion | $697.41 Million | 0.295x | +27.51% |
| 2018-12-31 | $2.40 Billion | $556.31 Million | 0.232x | +33.04% |
| 2017-12-31 | $2.31 Billion | $403.07 Million | 0.174x | +0.47% |
| 2016-12-31 | $2.30 Billion | $398.66 Million | 0.173x | +77.37% |
| 2015-12-31 | $1.94 Billion | $189.86 Million | 0.098x | -39.86% |
| 2014-12-31 | $1.86 Billion | $301.59 Million | 0.163x | +51.14% |
| 2013-12-31 | $1.95 Billion | $209.29 Million | 0.108x | -65.18% |
| 2012-12-31 | $2.07 Billion | $639.10 Million | 0.309x | -- |